BMN-365

N/A

Report date: 2024/05/20 10:13:12

Base Information

Drug NameBMN-365
Drug Alias NameBMN-365BMN 365
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionPlakophilin-2 gene transference
TargetsPlakophilin-2
Therapy Area/IndicationsCardiomyopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaN/A
Originator CompaniesBiomarin Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomarin Pharmaceutical Inc
Active IndicationsN/A
Inactive IndicationsCardiomyopathies

Other Information

ATC CodeN/A
Related LinksN/A